Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
08037 CH BIOTECH SER
RT Nominal unchange0.490 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
Investment Properties0--0000
Property, plant, equip. & others100,5354.644%96,07394,710128,79623,783
Land & other Lease Assets23,680-27.765%32,78210,78418,86313,135
Intangible Assets164,825-7.086%177,396201,493205,667210,601
Interests in Asso. & JCEs0--16,220000
Other Non-current Assets112,156-57.398%263,263122,021104,48282,622

401,196-31.505%585,734429,008457,808330,141
Current Assets
2023/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
Inventories9,274-50.473%18,7254,7385,5323,426
Trade Receivables19,764-97.371%751,89992,13030,31411,089
Cash & Bank Balances72,087-22.295%92,770150,554384,53945,518
Other Current Assets160,041649.150%21,36330,35225,92826,410
Assets Held for Sale0--0000

261,166-70.482%884,757277,774446,31386,443
Current Liabilities
2023/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
Trade Payables5,787-97.197%206,44116,149190,2333,404
S-T Debt & Leases94,669469.575%16,62163,61423,26236,121
Other Current Liabilities59,011-81.876%325,602147,63258,81914,234
Liab asso w/ Assets Held for Sale0--0000

159,467-70.935%548,664227,395272,31453,759
Net Current Assets101,699-69.741%336,09350,379173,99932,684
Total Assets Less Current Liabilities502,895-45.446%921,827479,387631,807362,825
Non-current Liabilities
2023/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
L-T Debt & Leases5,727-91.211%65,1633,55683,0786,085
Other Non-current Liabilities6,442-78.629%30,1449,93636,62443,377

12,169-87.232%95,30713,492119,70249,462
Capital and Reserves
2023/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
  Share Capital96,3230.000%96,32396,32396,68596,981
  Reserves366,431-27.633%506,352299,075246,646192,211
  Others0--0000
Shareholders' Funds462,754-23.217%602,675395,398343,331289,192
Non-controlling Interests27,972-87.504%223,84570,497168,77424,171
Others0--0000

490,726-40.627%826,520465,895512,105313,363
Commitments and Contingent Liabilities
2023/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
2019/12
HKD(K$)
Commitments208,374-12.717%238,7334004,9058,660
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 23/12/2024 15:15
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders ($)HKD -79,917,000
%Change162.160%
EPS / (LPS)HKD -0.083
NBV Per Share ($)HKD 0.405
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.